|
2013-04-10 |
2013-04-08 |
S
Sale
|
LICHTINGER PEDRO
Former CEO
|
90,000
-46.4%
14.73
USD 1,325,538
|
90,000
-46.4%
|
14.73
|
USD 1,325,538
|
|
|
2013-04-10 |
2013-04-08 |
S
Sale
|
LICHTINGER PEDRO
Former CEO
|
58,000
-23.0%
14.63
USD 848,453
|
58,000
-23.0%
|
14.63
|
USD 848,453
|
|
|
2012-11-19 |
2012-11-08 |
B
Purchase
|
LICHTINGER PEDRO
CEO and President
Officer
|
11,000
+11.8%
9.08
USD 99,847
|
11,000
+11.8%
|
9.08
|
USD 99,847
|
|
|
2012-06-20 |
2012-06-11 |
S
Sale
|
CHANG JOSEPH Y
Non-Executive Director
|
3,461
-3.3%
15.30
USD 52,953
|
3,461
-3.3%
|
15.30
|
USD 52,953
|
|
|
2011-08-09 |
2011-08-09 |
B
Purchase
|
ALTIG ANTHONY E
Non-Executive Director
|
5,000
+inf%
7.44
USD 37,213
|
5,000
+inf%
|
7.44
|
USD 37,213
|
|
|
2011-08-04 |
2011-08-04 |
B
Purchase
|
LICHTINGER PEDRO
CEO and President
Executive Director
|
25,000
+38.0%
8.98
USD 224,450
|
25,000
+38.0%
|
8.98
|
USD 224,450
|
|
|
2010-05-13 |
2010-05-12 |
S
Sale
|
CHANG JOSEPH Y
Non-Executive Director
|
3,461
-3.5%
11.75
USD 40,667
|
3,461
-3.5%
|
11.75
|
USD 40,667
|
|
|
2010-05-13 |
2010-05-12 |
S
Sale
|
CHANG JOSEPH Y
Non-Executive Director
|
4,615
-4.6%
11.75
USD 54,226
|
4,615
-4.6%
|
11.75
|
USD 54,226
|
|
|
2009-12-29 |
2009-12-29 |
B
Purchase
|
Chang Michael N
CEO and President
Executive Director
|
8,000
+3.8%
10.80
USD 86,400
|
8,000
+3.8%
|
10.80
|
USD 86,400
|
|
|
2009-12-29 |
2009-12-29 |
B
Purchase
|
Che Tessie M
COO and SVP
Officer
|
8,000
+3.8%
10.80
USD 86,400
|
8,000
+3.8%
|
10.80
|
USD 86,400
|
|
|
2009-12-29 |
2009-12-28 |
B
Purchase
|
Chang Michael N
CEO and President
Executive Director
|
10,000
+4.9%
10.85
USD 108,500
|
10,000
+4.9%
|
10.85
|
USD 108,500
|
|
|
2009-12-29 |
2009-12-28 |
B
Purchase
|
Che Tessie M
COO and SVP
Officer
|
10,000
+4.9%
10.85
USD 108,500
|
10,000
+4.9%
|
10.85
|
USD 108,500
|
|
|
2009-12-02 |
2009-12-02 |
B
Purchase
|
Shue Youe Kong
VP, Clinical Development
Officer
|
500
+0.6%
10.89
USD 5,445
|
500
+0.6%
|
10.89
|
USD 5,445
|
|
|
2009-12-02 |
2009-12-02 |
B
Purchase
|
Shue Youe Kong
VP, Clinical Development
Officer
|
500
+0.6%
10.90
USD 5,450
|
500
+0.6%
|
10.90
|
USD 5,450
|
|
|
2009-12-02 |
2009-12-02 |
B
Purchase
|
Shue Youe Kong
VP, Clinical Development
Officer
|
1,000
+1.2%
10.96
USD 10,960
|
1,000
+1.2%
|
10.96
|
USD 10,960
|
|
|
2009-12-02 |
2009-12-01 |
B
Purchase
|
Shue Youe Kong
VP, Clinical Development
Officer
|
1,000
+1.3%
11.10
USD 11,100
|
1,000
+1.3%
|
11.10
|
USD 11,100
|
|
|
2009-11-25 |
2009-11-25 |
B
Purchase
|
Che Tessie M
COO and SVP
Officer
|
7,000
+3.6%
11.50
USD 80,500
|
7,000
+3.6%
|
11.50
|
USD 80,500
|
|
|
2009-11-25 |
2009-11-25 |
B
Purchase
|
Chang Michael N
CEO and President
Executive Director
|
7,000
+3.6%
11.50
USD 80,500
|
7,000
+3.6%
|
11.50
|
USD 80,500
|
|
|
2009-11-25 |
2009-11-25 |
B
Purchase
|
Che Tessie M
COO and SVP
Officer
|
8,000
+4.3%
11.53
USD 92,240
|
8,000
+4.3%
|
11.53
|
USD 92,240
|
|
|
2009-11-25 |
2009-11-25 |
B
Purchase
|
Chang Michael N
CEO and President
Executive Director
|
8,000
+4.3%
11.53
USD 92,240
|
8,000
+4.3%
|
11.53
|
USD 92,240
|
|
|
2008-07-22 |
2008-07-18 |
B
Purchase
|
SCHREIBER ALAIN
Non-Executive Director
|
628,931
+inf%
8.48
USD 5,333,335
|
628,931
+inf%
|
8.48
|
USD 5,333,335
|
|
|
2008-07-22 |
2008-07-18 |
B
Purchase
|
SCHREIBER ALAIN
Non-Executive Director
|
314,465
+inf%
8.48
USD 2,666,663
|
314,465
+inf%
|
8.48
|
USD 2,666,663
|
|
|
2008-07-25 |
2008-07-02 |
S
Sale
|
EDELMAN JOSEPH
Large shareholder
|
8,000
-6.6%
7.40
USD 59,200
|
8,000
-6.6%
|
7.40
|
USD 59,200
|
|
|
2008-07-25 |
2008-07-02 |
S
Sale
|
EDELMAN JOSEPH
Large shareholder
|
192,000
-7.0%
7.40
USD 1,420,800
|
192,000
-7.0%
|
7.40
|
USD 1,420,800
|
|
|
2008-06-17 |
2008-06-13 |
B
Purchase
|
Chang Michael N
CEO and President
Executive Director
|
5,000
+3.0%
7.00
USD 35,000
|
5,000
+3.0%
|
7.00
|
USD 35,000
|
|
|
2008-06-17 |
2008-06-13 |
B
Purchase
|
Che Tessie M
COO and SVP
Officer
|
5,000
+3.0%
7.00
USD 35,000
|
5,000
+3.0%
|
7.00
|
USD 35,000
|
|
|
2008-05-16 |
2008-05-15 |
PP
Planned purchase
|
Che Tessie M
COO & SVP
Officer
|
2,500
+1.5%
6.04
USD 15,088
|
2,500
+1.5%
|
6.04
|
USD 15,088
|
|
|
2008-05-16 |
2008-05-15 |
PP
Planned purchase
|
Chang Michael N
CEO & President
Executive Director
|
2,042
+0.8%
6.04
USD 12,323
|
2,042
+0.8%
|
6.04
|
USD 12,323
|
|
|
2007-12-27 |
2007-12-19 |
S
Sale
|
EDELMAN JOSEPH
Large shareholder
|
12,220
-0.4%
7.75
USD 94,683
|
12,220
-0.4%
|
7.75
|
USD 94,683
|
|
|
2007-12-27 |
2007-12-18 |
S
Sale
|
EDELMAN JOSEPH
Large shareholder
|
1,464
-1.2%
7.71
USD 11,292
|
1,464
-1.2%
|
7.71
|
USD 11,292
|
|
|
2007-12-27 |
2007-12-18 |
S
Sale
|
EDELMAN JOSEPH
Large shareholder
|
22,936
-0.8%
7.71
USD 176,905
|
22,936
-0.8%
|
7.71
|
USD 176,905
|
|
|
2007-12-27 |
2007-12-17 |
S
Sale
|
EDELMAN JOSEPH
Large shareholder
|
756
-0.6%
7.71
USD 5,829
|
756
-0.6%
|
7.71
|
USD 5,829
|
|
|
2007-12-27 |
2007-12-17 |
S
Sale
|
EDELMAN JOSEPH
Large shareholder
|
11,844
-0.4%
7.71
USD 91,321
|
11,844
-0.4%
|
7.71
|
USD 91,321
|
|
|
2007-12-27 |
2007-12-13 |
S
Sale
|
EDELMAN JOSEPH
Large shareholder
|
780
-0.6%
7.75
USD 6,044
|
780
-0.6%
|
7.75
|
USD 6,044
|
|
|
2007-12-27 |
2007-12-13 |
S
Sale
|
EDELMAN JOSEPH
Large shareholder
|
348
-0.3%
7.38
USD 2,569
|
348
-0.3%
|
7.38
|
USD 2,569
|
|
|
2007-12-27 |
2007-12-13 |
S
Sale
|
EDELMAN JOSEPH
Large shareholder
|
5,452
-0.2%
7.38
USD 40,245
|
5,452
-0.2%
|
7.38
|
USD 40,245
|
|
|
2007-11-19 |
2007-11-15 |
B
Purchase
|
Chang Michael N
CEO
Executive Director
|
1,000
+0.4%
5.95
USD 5,950
|
1,000
+0.4%
|
5.95
|
USD 5,950
|
|
|
2007-11-19 |
2007-11-15 |
PP
Planned purchase
|
Che Tessie M
COO
Officer
|
1,000
+0.6%
5.95
USD 5,950
|
1,000
+0.6%
|
5.95
|
USD 5,950
|
|
|
2007-11-19 |
2007-11-15 |
B
Purchase
|
Chang Michael N
CEO
Executive Director
|
1,000
+0.6%
5.95
USD 5,950
|
1,000
+0.6%
|
5.95
|
USD 5,950
|
|
|
2007-11-19 |
2007-11-15 |
PP
Planned purchase
|
Poulos Kevin P
Chief Commercial Officer
Officer
|
1,000
+166.7%
5.95
USD 5,950
|
1,000
+166.7%
|
5.95
|
USD 5,950
|
|
|
2007-11-19 |
2007-11-15 |
PP
Planned purchase
|
Che Tessie M
COO
Officer
|
1,000
+0.4%
5.95
USD 5,950
|
1,000
+0.4%
|
5.95
|
USD 5,950
|
|
|
2007-11-19 |
2007-11-15 |
PP
Planned purchase
|
Prunty John D
CFO
Officer
|
1,000
+inf%
5.95
USD 5,950
|
1,000
+inf%
|
5.95
|
USD 5,950
|
|
|
2007-11-19 |
2007-11-15 |
PP
Planned purchase
|
Shue Youe Kong
VP Clinical Development
Officer
|
1,000
+1.3%
5.95
USD 5,950
|
1,000
+1.3%
|
5.95
|
USD 5,950
|
|
|
2007-08-13 |
2007-08-10 |
B
Purchase
|
Shue Youe Kong
VP Clinical Development
Officer
|
300
+0.4%
8.24
USD 2,472
|
300
+0.4%
|
8.24
|
USD 2,472
|
|
|
2007-08-13 |
2007-08-10 |
B
Purchase
|
Shue Youe Kong
VP Clinical Development
Officer
|
200
+0.3%
8.27
USD 1,654
|
200
+0.3%
|
8.27
|
USD 1,654
|
|
|
2007-08-13 |
2007-08-10 |
B
Purchase
|
Shue Youe Kong
VP Clinical Development
Officer
|
100
+0.1%
8.28
USD 828
|
100
+0.1%
|
8.28
|
USD 828
|
|
|
2007-08-13 |
2007-08-10 |
B
Purchase
|
Shue Youe Kong
VP Clinical Development
Officer
|
200
+0.3%
8.29
USD 1,658
|
200
+0.3%
|
8.29
|
USD 1,658
|
|
|
2007-08-13 |
2007-08-10 |
B
Purchase
|
Shue Youe Kong
VP Clinical Development
Officer
|
1,200
+1.7%
8.30
USD 9,960
|
1,200
+1.7%
|
8.30
|
USD 9,960
|
|
|
2007-08-13 |
2007-08-09 |
B
Purchase
|
Shue Youe Kong
VP Clinical Development
Officer
|
500
+0.7%
8.30
USD 4,150
|
500
+0.7%
|
8.30
|
USD 4,150
|
|
|
2007-08-10 |
2007-08-09 |
B
Purchase
|
Chang Michael N
President & CEO
Executive Director
|
30,000
+21.5%
8.20
USD 246,000
|
30,000
+21.5%
|
8.20
|
USD 246,000
|
|
|
2007-08-10 |
2007-08-09 |
B
Purchase
|
Che Tessie M
Senior VP & COO
Officer
|
30,000
+21.5%
8.20
USD 246,000
|
30,000
+21.5%
|
8.20
|
USD 246,000
|
|
|
2007-08-08 |
2007-08-06 |
B
Purchase
|
Che Tessie M
Senior VP & COO
Officer
|
10,000
+7.7%
9.05
USD 90,500
|
10,000
+7.7%
|
9.05
|
USD 90,500
|
|
|
2007-08-08 |
2007-08-06 |
B
Purchase
|
Chang Michael N
President and CEO
Executive Director
|
10,000
+7.7%
9.05
USD 90,500
|
10,000
+7.7%
|
9.05
|
USD 90,500
|
|
|
2007-08-08 |
2007-07-16 |
B
Purchase
|
Che Tessie M
Senior VP & COO
Officer
|
5,000
+4.0%
9.80
USD 49,000
|
5,000
+4.0%
|
9.80
|
USD 49,000
|
|
|
2007-08-08 |
2007-07-16 |
B
Purchase
|
Che Tessie M
Senior VP & COO
Officer
|
5,000
+4.2%
9.92
USD 49,600
|
5,000
+4.2%
|
9.92
|
USD 49,600
|
|
|
2007-07-18 |
2007-07-16 |
B
Purchase
|
Chang Michael N
President, CEO
Executive Director
|
5,000
+4.0%
9.80
USD 49,000
|
5,000
+4.0%
|
9.80
|
USD 49,000
|
|
|
2007-07-18 |
2007-07-16 |
B
Purchase
|
Chang Michael N
President, CEO
Executive Director
|
5,000
+4.2%
9.92
USD 49,600
|
5,000
+4.2%
|
9.92
|
USD 49,600
|
|
|
2007-02-23 |
2007-02-21 |
S
Sale
|
Par Pharmacuetical, Inc.
Large shareholder
|
1,050,000
-45.5%
7.00
USD 7,350,000
|
1,050,000
-45.5%
|
7.00
|
USD 7,350,000
|
|
|
2007-02-14 |
2007-02-14 |
B
Purchase
|
Chang Michael N
President, CEO
Executive Director
|
114,965
+2491.1%
7.00
USD 804,755
|
114,965
+2491.1%
|
7.00
|
USD 804,755
|
|
|
2007-02-14 |
2007-02-14 |
B
Purchase
|
Poulos Kevin P
VP, Marketing and Sales
Officer
|
600
+inf%
7.00
USD 4,200
|
600
+inf%
|
7.00
|
USD 4,200
|
|
